COVID-19 vaccine Sinopharm gains WHO emergency approval

By Christine Fabro

The World Health Organization (WHO) granted emergency use for the Sinopharm COVID-19 vaccine yesterday (May 7) to be rolled out globally – the first Chinese-made vaccine to gain WHO approval.

According to Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products, this additional listing has the potential to “rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk.”

The vaccine has an efficacy rate of 79% for symptomatic and hospitalized cases, and is recommended for adults 18 years and older, administered in a two-dose schedule.

The Sinopharm COVID-19 vaccine is also the first vaccine that will carry a vaccine vial monitor, which indicates whether the vaccine can be safely used and its easy storage requirements makes it highly suitable for low-resource settings.

WHO previously listed Pfizer/BioNTech, AstraZeneca/Oxford, Serum Institute of India, Janssen, and Moderna vaccines for emergency use. –WHO/CF-RIR

Popular

Gov’t remains ‘relentless’ in supporting PH Air Force — PBBM

By Brian Campued President Ferdinand R. Marcos Jr. reaffirmed his administration’s continued support to the Filipino airmen and airwomen as the Philippine Air Force (PAF)...

PBBM ‘rings’ CMEPA into effectivity

By Dean Aubrey Caratiquet Investments serve as the lifeblood of a successful and progressive nation, paving the way for an economy that adopts to the...

‘Best is yet to come’: PBBM rallies Alex Eala after WTA finals debut

By Darryl John Esguerra | Philippine News Agency On Sunday, June 29, President Ferdinand R. Marcos Jr. offered words of encouragement to tennis sensation Alex...

DOH opens online mental health support for Filipinos in Israel

By Joyce Ann L. Rocamora | Philippine News Agency The Department of Health (DOH) is extending psychosocial support to overseas Filipinos in Israel affected by...